In the remaining 31 cancers, there were no statistically significant difference in TMEM158 expression in 7 cancers (adrenocortical carcinoma, ACC; bladder urothelial carcinoma, BLCA; lower grade glioma, LGG; liver hepatocellular carcinoma, LIHC; sarcoma, SARC; testicular germ cell tumors, TGCT; thymoma, THYM). This evidence concerns the gene TMEM158 and sarcoma.